Pharmaceutical Regulatory Affairs plays a pivotal role in ensuring the safety, efficacy, and quality of pharmaceutical products, acting as the liaison between pharmaceutical companies and regulatory authorities. This dynamic field navigates the complex landscape of regulations and guidelines, shaping the development, manufacturing, and marketing of drugs.
Professionals in Regulatory Affairs are responsible for interpreting and implementing regulatory requirements to ensure compliance throughout the drug development lifecycle. They work closely with cross-functional teams to strategize and execute regulatory submissions, seeking approvals from health authorities such as the FDA, EMA, and other regulatory bodies worldwide.
The regulatory landscape is ever-evolving, and Regulatory Affairs professionals stay abreast of changes, guiding companies through the intricacies of new guidelines and ensuring adherence to established standards. They contribute to the successful launch and post-marketing surveillance of pharmaceutical products, addressing challenges related to labeling, safety reporting, and product recalls.
Pharmaceutical Regulatory Affairs professionals also play a crucial role in fostering international harmonization, facilitating global drug development and access. Their expertise is instrumental in navigating the complex web of regulations, ultimately contributing to the availability of safe and effective medicines for patients worldwide.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada